Assessing Blood
Glucose, Blood Lipid, and Blood Preassure Control
Using assessment levels
to set targets
 |
| Use the assessment levels
for glucose, lipids, and blood pressure : |
 |
 |
as an integral part of diabetes care - do not manage diabetes on symptoms alone |
|
 |
to indicate need for further intervention |
|
 |
as the basis for short-term and longer-term individualized targets |
|
 |
as an educational tool to help the person with diabetes |

Ask yourself the following at consultations : |
|

 |
Is it possible for the individual to approach each target more closely, without a counter-balancing deterioration in quality of
life? |

Be concerned about targets : |
|

 |
Failure to attempt to reach agreed targets is inadequate care, unless this would lead to deterioration in quality of life |
|
|
 |
Assessment
of blood glucose, blood lipid, and blood preassure control
 |
| Measure : |

 |
glycated haemoglobin 2-6 monthly |

 |
the blood lipid profile ( total, LDL, and HDL cholesterol, and triglycerides ) 2-6 monthly if previously above assessment levels ( see next page ), otherwise annually |

 |
blood pressure at each consultation unless known to be below assessment levels |
|

Use the assessment levels ( next page ) to set individual blood glucose, blood lipid and blood pressure targets, depending on overall risk and what it may be possible to achieve within a foreseeable time period |

Modify individual targets at least yearly in the light of past success, and if any change in clinical circumstances |
 |
|
|
 |
|

Blood glucose control assessment levels
 |
 |
 |
|
Low
risk |
Arterial risk |
Microcascular
risk |
 |
 |
 |

HbA1c (DCCT standardized) |
|
|
|
| |
%Hb |
<=6.5 |
>6.5 |
>7.5 |
| |

Venous plasma glucose |
|
|
|
| |
Fasting /
pre-prandial |
|
|
|
| |
mmol/l |
<=6.0 |
>6.0 |
>=7.0 |
| |
mg/dl |
<110 |
>=110 |
>125 |
| |

Self-monitored blood glucose |
|
|
|
| |
Fasting /
pre-prandial |
|
|
|
| |
mmol/l |
<=5.5 |
>5.5 |
>6.0 |
| |
mg/dl |
<100 |
>=100 |
>=110 |
| |
Post-prandial
(peak) |
|
|
|
| |
mmol/l |
<7.5 |
>=7.5 |
>9.0 |
| |
mg/dl |
<135 |
>=135 |
>160 |
| |
 |
|
|
|
|
Fasting capillary blood glucose is around 1.0 mmol/l (18 mg/dl) lower than venous plasma;
post-prandial capillary blood glucose is the same as venous plasma
|
Blood
lipid control assessment levels
 |
 |
 |
|
Low
risk |
At risk |
High
risk |
 |
 |
| |

Serum total cholesterol |
|
|
|
| |
mmol/l |
<4.8 |
4.8-6.0 |
>6.5 |
| |
mg/dl |
<185 |
185-230 |
>230 |
| |

Serum LDL cholesterol |
|
|
|
| |
mmol/l |
<3.0 |
3.0-4.0 |
>4.0 |
| |
mg/dl |
<115 |
115-155 |
>155 |
| |

Serum HDL cholesterol |
|
|
|
| |
mmol/l |
>1.2 |
1.0-1.2 |
>1.0 |
| |
mg/dl |
>46 |
39-46 |
>39 |
| |

Serum triglycerides |
|
|
|
| |
mmol/l |
<1.7 |
1.7-2.2 |
>2.2 |
| |
mg/dl |
<150 |
150-200 |
>200 |
| |
 |
|
|
|
|

|
Blood
pressure control assessment levels
 |
| Low risk ( mmHg ) |
<141/85 |
|
 |
|